摘要 |
Compounds of formula (I): wherein: A<SUP>1 </SUP>is phenyl, a six-membered aromatic heterocycle containing one, two or three nitrogen atoms, or a five-membered aromatic heterocycle containing up to four heteroatoms chosen from O, N and S, at most one heteroatom being O or S; A<SUP>2 </SUP>is phenyl, a six-membered aromatic heterocycle containing one, two or three nitrogen atoms, or a five-membered aromatic heterocycle containing up to four heteroatoms chosen from O, N and S, at most one heteroatom being O or S; L is a bond or C<SUB>1-6</SUB>alkylene; R<SUP>1 </SUP>and R<SUP>2 </SUP>independently chosen from hydrogen and C<SUB>1-6</SUB>alkyl or R<SUP>1 </SUP>and R<SUP>2 </SUP>may, together, form a methylene or ethylene bridge; W is halogen, C<SUB>1-6</SUB>alkyl, haloC<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkoxy or haloC<SUB>1-6</SUB>alkoxy; X is O, S or NR<SUP>3 </SUP>or X, together with the atom to which it is attached, and Y, form an unsaturated five-membered ring together with A<SUP>2</SUP>; Y is a bond, C<SUB>1-4</SUB>alkylene, NH or NH(CH<SUB>2</SUB>)<SUB>1-3</SUB>; or a pharmaceutically acceptable salt thereof; other substituents are defined in claim 1 ; which are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).
|